Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial.
Journal Information
Full Title: Br J Cancer
Abbreviation: Br J Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding This work was supported by National Cancer Institute Grant P01 CA081403, St. Baldrick’s Foundation, V Foundation for Cancer Research, Department of Defense Grant CA1702571, Alex’s Lemonade Stand Foundation and ALSF Center of Excellence, Hyundai Hope on Wheels, the Kids Cancer Project, Australian Lions Children’s Cancer Research Fund and an anonymous donor. Open access funding provided by SCELC, Statewide California Electronic Library Consortium."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025